Direct effect of alginate purification on the survival of islets immobilized in alginate-based microcapsules

Acta Biomaterialia

Volumn 5, Issue 9, 2009, Pages 3433-3440

  Langlois, Geneviève ^a   Dusseault, Julie ^a   Bilodeau, Stéphanie ^a   Tam, Susan K ^a,b   Magassouba, Dalla ^a,c   Hallé, Jean Pierre ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

^b ÉCOLE POLYTECHNIQUE DE MONTRÉAL   (Canada)

^c UNIVERSITÉ DU QUÉBEC À TROIS RIVIÈRES   (Canada)

Author keywords

Alginate purification; Cell viability; Islets of Langerhans; Microencapsulation

Indexed keywords

ALGINATE; CELL DEATH; ENCAPSULATION; MICROSTRUCTURE;

ALGINATE PURIFICATION; ALGINATE-BASED MICROCAPSULES; APOPTOTIC CELLS; CELL SURVIVAL; CELL VIABILITY; HOST IMMUNE RESPONSE; ISLET CELLS; ISLETS OF LANGERHANS; RAT ISLETS; WISTAR RAT;

PURIFICATION;

ACRIDINE ORANGE; BIOMATERIAL; CALCIUM ALGINATE; PROPIDIUM IODIDE;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CELL ENCAPSULATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; CULTURE MEDIUM; ENCAPSULATION; HOST; IMMOBILIZATION; IMMUNE RESPONSE; IN VIVO STUDY; INCUBATION TIME; MICROCAPSULE; MICROSCOPY; NICK END LABELING; NONHUMAN; PANCREAS ISLET CELL; PRIORITY JOURNAL; PURIFICATION; QUANTITATIVE ANALYSIS; RAT; TISSUE SURVIVAL;

RATTUS NORVEGICUS;

EID: 70349847426     PISSN: 17427061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actbio.2009.05.029     Document Type: Article

References (41)

1. Shapiro A.M., Lakey J.R., Ryan E.A., Korbutt G.S., Toth E., Warnock G.L., et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 343 4 (2000) 230-238
2. Ryan E.A., Lakey J.R., Rajotte R.V., Korbutt G.S., Kin T., Imes S., et al. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes 50 4 (2001) 710-719
3. Ryan E.A., Paty B.W., Senior P.A., Bigam D., Alfadhli E., Kneteman N.M., et al. Five-year follow-up after clinical islet transplantation. Diabetes 54 7 (2005) 2060-2069
4. Nathan D.M., Cleary P.A., Backlund J.Y., Genuth S.M., Lachin J.M., Orchard T.J., et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 353 25 (2005) 2643-2653
5. Lim F., and Sun A.M. Microencapsulated islets as bioartificial endocrine pancreas. Science 210 4472 (1980) 908-910
6. de Vos P., Andersson A., Tam S.K., Fass M., and Hallé J. Advances and barriers in mammalian cell encapsulation for treatment of diabetes. Immun Endoc Metab Agents Med Chem 6 (2006) 139-153
7. Orive G., Tam S.K., Pedraz J.L., and Halle J.P. Biocompatibility of alginate-poly-l-lysine microcapsules for cell therapy. Biomaterials 27 20 (2006) 3691-3700
8. Halle JP, de Vos P, Rosenberg L, editors. The Bioartificial Pancreas and other Biohybrid Therapies. Kerala, India: Research Signpost; ISBN: 978-81-7895-415-8, 2009.
9. Korbutt G.S., Mallett A.G., Ao Z., Flashner M., and Rajotte R.V. Improved survival of microencapsulated islets during in vitro culture and enhanced metabolic function following transplantation. Diabetologia 47 10 (2004) 1810-1818
10. 2+ microbeads: in vitro and in vivo function. Artificial Cells Blood Substit Biotechnol 36 5 (2008) 403-420
11. Dusseault J, Hallé J. Alginate hydrogels for cell microencapsulation and immunoprotection. In: Hu J, editor. Recent Advances in Biomaterials Research. Kerala, India: Research Signpost; ISBN: 978-81-7895-332-8, 2008.
12. Aomatsu Y., Iwata H., Takagi T., Amemiya H., Nakajima Y., Hanehiro H., et al. Microencapsulated islets in agarose gel as bioartificial pancreas for discordant xenotransplantation. Transplant Proc 24 (1992) 2922-2923
13. Laurent T.C., and Fraser J.R. Hyaluronan. FASEB J 6 7 (1992) 2397
14. de Vos P., de Haan B.J., Wolters G.H., Strubbe J.H., and Van Schilfgaarde R. Improved biocompatibility but limited graft survival after purification of alginate for microencapsulation of pancreatic islets. Diabetologia 40 3 (1997) 262-270
15. Prokop A., and Wang T.G. Purification of polymers used for fabrication of an immunoisolation barrier. Ann NY Acad Sci 831 (1997) 223-231
16. Klock G., Frank H., Houben R., Zekorn T., Horcher A., Siebers U., et al. Production of purified alginates suitable for use in immunoisolated transplantation. Appl Microbiol Biotechnol 40 5 (1994) 638-643
17. Wandrey C., and Vidal D.S. Purification of polymeric biomaterials. Ann NY Acad Sci 944 (2001) 187-198
18. Lacik I., Brissova M., Anilkumar A.V., Powers A.C., and Wang T. New capsule with tailored properties for the encapsulation of living cells. J Biomed Mater Res 39 1 (1998) 52-60
19. Chandy T., Mooradian D.L., and Rao G.H.R. Evaluation of modified alginate-chitosan-polyethylene glycol microcapsules for cell encapsulation. Artif Organs 23 (1999) 894-903
20. Ménard M, Dusseault J, Langlois G, Baille W, Tam S, Yahia L, et al. Role of protein contaminants in the immunogenicity of alginates. J Biomed Mater Res B Appl Biomater, in press.
21. Gotoh M., Maki T., Kiyoizumi T., Satomi S., and Monaco A.P. An improved method for isolation of mouse pancreatic islets. Transplantation 40 (1985) 437-438
22. Hallé J.P., Leblond F.A., Pariseau J.F., Jutras P., Brabant M.J., and Lepage Y. Studies on small (<300 microns) microcapsules. II. Parameters governing the production of alginate beads by high voltage electrostatic pulses. Cell Transplant 3 5 (1994) 365-372
23. Bank H.L. Assessment of islet cell viability using fluorescent dyes. Diabetologia 30 10 (1987) 812-816
24. Bank H.L. Rapid assessment of islet viability with acridine orange and propidium iodide. In Vitro Cell Dev Biol 24 4 (1988) 266-273
25. Miyamoto M., Morimoto Y., Nozawa Y., Balamurugan A.N., Xu B., and Inoue K. Establishment of fluorescein diacetate and ethidium bromide (FDAEB) assay for quality assessment of isolated islets. Cell Transplant 9 5 (2000) 681-686
26. Robitaille R., Dusseault J., Henley N., Rosenberg L., and Hallé J. IGF-II allows prolonged blood glucose normalization with a reduced islet cell mass transplantation. Endocrinology 144 7 (2003) 3037-3045
27. Ilieva A., Yuan S., Wang R.N., Agapitos D., Hill D.J., and Rosenberg L. Pancreatic islet cell survival following islet isolation: the role of cellular interactions in the pancreas. J Endocrinol 161 3 (1999) 357-364
28. Zhang W.J., Laue C., Hyder A., and Schrezenmeir J. Purity of alginate affects the viability and fibrotic overgrowth of encapsulated porcine islet xenografts. Transplant Proc 33 7-8 (2001) 3517-3519
29. Mallett A.G., and Korbutt G.S. Alginate modification improves long-term survival and function of transplanted encapsulated islets. Tissue Eng A 15 6 (2009) 1301-1309
30. Zimmermann U., Klock G., Federlin K., Hannig K., Kowalski M., Bretzel R.G., et al. Production of mitogen-contamination free alginates with variable ratios of mannuronic acid to guluronic acid by free flow electrophoresis. Electrophoresis 13 5 (1992) 269-274
31. Vargas F., Vives-Pi M., Somoza N., Armengol P., Alcalde L., Marti M., et al. Endotoxin contamination may be responsible for the unexplained failure of human pancreatic islet transplantation. Transplantation 65 5 (1998) 722-727
32. Brandhorst H., Brandhorst D., Brendel M.D., Hering B.J., and Bretzel R.G. Assessment of intracellular insulin content during all steps of human islet isolation procedure. Cell Transplant 7 5 (1998) 489-495
33. Jahr H., Pfeiffer G., Hering B.J., Federlin K., and Bretzel R.G. Endotoxin-mediated activation of cytokine production in human PBMCs by collagenase and Ficoll. J Mol Med 77 1 (1999) 118-120
34. Vargas F., Vives-Pi M., Somoza N., Fernandez-Llamazares J., and Pujol-Borrell R. Endotoxin activity of collagenase and human islet transplantation. Lancet 350 9078 (1997) 641
35. Arnush M., Heitmeier M.R., Scarim A.L., Marino M.H., Manning P.T., and Corbett J.A. IL-1 produced and released endogenously within human islets inhibits beta cell function. J Clin Invest 102 3 (1998) 516-526
36. Corbett J.A., and McDaniel M.L. Intraislet release of interleukin-1 inhibits beta cell function by inducing beta cell expression of inducible nitric oxide synthase. J Exp Med 181 (1995) 559-569
37. Vives-Pi M., Somoza N., Fernandez-Alvarez J., Vargas F., Caro P., Alba A., et al. Evidence of expression of endotoxin receptors CD14, toll-like receptors TLR4 and TLR2 and associated molecule MD-2 and of sensitivity to endotoxin (LPS) in islet beta cells. Clin Exp Immunol 133 2 (2003) 208-218
38. Comstock K.L., Krown K.A., Page M.T., Martin D., Ho P., Pedraza M., et al. LPS-induced TNF-alpha release from and apoptosis in rat cardiomyocytes: obligatory role for CD14 in mediating the LPS response. J Mol Cell Cardiol 30 12 (1998) 2761-2775
39. Tam S.K., Dusseault J., Polizu S., Menard M., Halle J.P., and Yahia L. Impact of residual contamination on the biofunctional properties of purified alginates used for cell encapsulation. Biomaterials 27 8 (2006) 1296-1305
40. Klock G., Pfeffermann A., Ryser C., Grohn P., Kuttler B., Hahn H.J., et al. Biocompatibility of mannuronic acid-rich alginates. Biomaterials 18 (1997) 707-713
41. Zekorn T., Siebers U., Bretzel R.G., Heller S., Meder U., Ruttkay H., et al. Impact of the perfluorochemical FC43 on function of isolated islets: a preliminary report. Horm Metab Res 23 6 (2001) 302-303